top of page
Search

TESOFENSINE: TRIPLE REUPTAKE INHIBITOR FOR ADVANCED WEIGHT LOSS


OVERVIEW:

  • Tesofensine is a triple monoamine reuptake inhibitor affecting serotonin, norepinephrine, and dopamine 

  • Originally developed for neurodegenerative diseases (Parkinson's, Alzheimer's) 

  • Tesofensine was originally studied as a neurotransmitter reuptake inhibitor for neurodegenerative conditions like Parkinson's and Alzheimer's disease 

  • Discovered to have potent weight loss effects during clinical trials 

  • Research compound with significant clinical trial data


WHAT DOES TESOFENSINE DO?

  • Provides powerful appetite suppression through neurotransmitter modulation 

  • Promotes significant weight loss (up to 25 pounds in 6 months) 

  • It mainly works by blocking the reuptake of norepinephrine, dopamine, and serotonin. This helps increase their levels in the brain 

  • Enhances mood and energy levels during weight loss 

  • Improves metabolic function and energy expenditure 

  • Supports long-term weight maintenance 

  • Reduces food cravings and emotional eating


USES:

  • Significant obesity and weight loss 

  • Appetite suppression and craving control 

  • Body composition improvement 

  • Metabolic health optimization 

  •  Mood support during weight loss 

  • Long-term weight maintenance 

  • Treatment-resistant weight loss cases


TESOFENSINE RESEARCH


Superior Weight Loss Efficacy: Clinical trials suggest that tesofensine 0.5 mg might have the potential to produce a weight loss twice that of currently approved drugs. Patients lost an average of 12.8 kg on the 1 mg dose, 11.3 kg on the 0.5 mg dose and 6.7 kg on the 0.25 mg dose, compared with a 2.2 kg loss in the placebo group.


Triple Mechanism Action: Tesofensine aids weight loss by impacting neurotransmitters in the brain—specifically dopamine, serotonin, and norepinephrine—that regulate appetite and mood. This triple action provides comprehensive appetite control and mood support during weight loss.


Dose-Dependent Effects: Daily doses of 1 mg administered over 24 weeks are associated with a 10.6% body weight reduction, demonstrating clear dose-response relationships for weight loss effectiveness.


Long-Acting Profile: Because tesofensine has a long half-life (over 8 days), some side effects can stick around longer, but this also means sustained appetite suppression with once-daily dosing.


Neurological Mechanisms: Research found that tesofensine induces a greater weight loss in obese rats than lean rats, while differentially modulating the neuronal ensembles and population activity in the lateral hypothalamus, explaining its effectiveness in obesity.


Clinical Safety Profile: The most commonly reported side effects in the obese population were dry mouth, headache, nausea, insomnia, diarrhea and constipation. A dose-dependent pattern was observed for dry mouth and insomnia.


Mechanism of Action: Tesofensine works through triple neurotransmitter modulation:

  1. Serotonin Reuptake Inhibition:

    • Enhanced satiety signaling

    • Improved mood during caloric restriction

    • Reduced carbohydrate cravings

    • Better impulse control around food


  1. Norepinephrine Reuptake Inhibition:

    • Increased metabolic rate and thermogenesis

    • Enhanced fat oxidation

    • Improved energy levels

    • Appetite suppression through sympathetic activation


  1. Dopamine Reuptake Inhibition:

    • Reduced food reward seeking behavior

    • Improved mood and motivation

    • Better adherence to weight loss programs

    • Reduced emotional eating patterns


  1. Hypothalamic Effects:

    • Direct action on appetite control centers

    • Modulation of hunger and satiety signals

    • Enhanced leptin sensitivity

    • Improved energy balance regulation


TESOFENSINE LIFESTYLE SUPPORT


LIFESTYLE SUPPORT: • We don't recommend using tesofensine without medical supervision. Because it affects your heart rate, mood, and metabolism, long-term safety depends on having someone track your progress • High-quality protein intake to prevent muscle loss during rapid weight loss • Regular cardiovascular monitoring due to stimulant-like effects • Adequate hydration and electrolyte replacement • Sleep hygiene optimization (may cause insomnia) • Stress management techniques • Regular physical activity within tolerance


WHAT TO EXPECT:


IMPORTANT: This is a powerful compound requiring medical supervision!

Week 1-2: Significant appetite reduction and possible side effects 

Week 3-4: Steady weight loss (2-4 lbs/week) and side effect adaptation 

Week 4-12: Sustained weight loss and appetite control 

Week 12-24: Its 6-month weight loss results from research trials resulted in a weight loss of around 25 pounds 

Long-term: Continued weight maintenance with sustained appetite control • Side effects typically stabilize after initial weeks


TESOFENSINE DOSING PROTOCOLS

PROTOCOL 1: CONSERVATIVE INITIATION

Standard Clinical Starting Protocol:

Week

Dose

10mg Vial Preparation

Volume

Supply Duration

1-2

0.25mg

10mg + 4mL = 2.5mg/mL

0.1mL (10 units)

40 days

3-4

0.5mg

Same preparation

0.2mL (20 units)

20 days

5+

0.5-1mg

Adjust based on response

0.2-0.4mL

10-20 days

Timeline: Most users find effective results between 0.25 mg and 1 mg per day, with 0.5 mg emerging as the clinical sweet spot for fat loss and tolerability



PROTOCOL 2: STANDARD THERAPEUTIC PROTOCOL

Clinically Effective Dosing:

Phase

Duration

Daily Dose

Preparation

Expected Weight Loss

Initiation

2 weeks

0.25mg

10mg + 4mL = 2.5mg/mL

2-4 lbs

Optimization

4-8 weeks

0.5mg

Same preparation

8-15 lbs

Maintenance

12+ weeks

0.5mg

Same preparation

15-25 lbs total

PROTOCOL 3: MAXIMUM EFFICACY PROTOCOL

Higher Dose for Treatment-Resistant Cases:

Phase

Daily Dose

Clinical Consideration

Monitoring Required

Week 1-2

0.25mg

Assess tolerance

Daily vitals

Week 3-6

0.5mg

Monitor for efficacy

Weekly check-ins

Week 7+

0.75-1mg

Maximum clinical dose

Enhanced monitoring

Note: Higher doses increase side effect risk and require intensive medical supervision


ADMINISTRATION PROTOCOLS:


Oral Administration: • 0.5mg tablets, with tailored protocols for every individual • Once daily, preferably morning • Can be taken with or without food • Consistent timing important for steady levels


Injectable Preparation (If Using Research Form): • Subcutaneous administration • 10mg vial + 4mL bacteriostatic water = 2.5mg/mL • Daily injection at consistent time • Rotate injection sites


Timing Optimization: • Morning Preferred: Minimizes sleep interference • Consistent


Schedule: Same time daily for steady levels • With Food: May reduce GI side effects • Avoid


Evening: Due to long half-life and insomnia risk


SAFETY MONITORING REQUIREMENTS:


Cardiovascular Monitoring: • Increases in heart rate and blood pressure were also observed. In clinical trials, heart rate went up by about 7 beats per minute at a common dose of 0.5 mg • Weekly blood pressure and heart rate checks initially • ECG monitoring for patients with cardiac risk factors • Immediate discontinuation if significant cardiovascular changes


Psychiatric Monitoring: • Tesofensine's synaptic effect can lead to serious psychiatric events (agitation, panic attacks, mood disorders) • Regular mood and psychiatric assessments • Monitor for agitation, panic attacks, or mood changes • Discontinue if serious psychiatric symptoms develop


Side Effect Management: • Common side effects reported with Tesofensine include: Dry Mouth (Xerostomia): A frequently reported side effect • Side effects such as dry mouth, insomnia, tachycardia, constipation, nausea, diarrhea, high blood pressure and increases in heart rate were recorded


COMPREHENSIVE SIDE EFFECT MANAGEMENT:


Common Side Effects (Manageable): • Dry Mouth: Increase fluid intake, sugar-free gum, oral moisturizers • Insomnia: Morning dosing, sleep hygiene, avoid caffeine • Nausea: Take with food, smaller meals, ginger supplements • Constipation: Increase fiber, adequate hydration, probiotics • Headache: Adequate hydration, electrolyte balance


Serious Side Effects (Require Medical Attention): • Cardiovascular: Chest pain, severe palpitations, shortness of breath • Psychiatric: Severe agitation, panic attacks, suicidal thoughts • Neurological: Severe headaches, vision changes, seizures • Metabolic: Severe dehydration, electrolyte imbalances


LIFESTYLE OPTIMIZATION FOR MAXIMUM BENEFITS:


Cardiovascular Health: • Regular moderate exercise within tolerance • Monitor heart rate during activities • Avoid excessive stimulants (caffeine, energy drinks) • Stay well-hydrated • Electrolyte supplementation if needed


Sleep Optimization: • Strict morning dosing schedule • Sleep hygiene practices • Cool, dark sleeping environment • Consider melatonin if needed (with medical approval) • Avoid screens before bedtime


Nutritional Support: • High-protein diet to preserve muscle mass • Adequate vitamins and minerals during rapid weight loss • Small, frequent meals to manage nausea • Fiber supplementation for constipation • Omega-3 fatty acids for cardiovascular support


CONTRAINDICATIONS AND PRECAUTIONS:


Absolute Contraindications: • Cardiovascular disease (recent MI, arrhythmias, severe hypertension) • Psychiatric disorders (bipolar disorder, severe depression, psychosis) • Uncontrolled hyperthyroidism • Pregnancy or breastfeeding • MAO inhibitor use within 14 days


Relative Contraindications: • Mild hypertension (requires monitoring) • History of eating disorders • Substance abuse history • Liver or kidney dysfunction • Age >65 years (increased monitoring required)


Drug Interactions: • MAO inhibitors (contraindicated) • Other serotonergic drugs (serotonin syndrome risk) • Stimulant medications (additive cardiovascular effects) • Antihypertensive medications (may require adjustment)


MONITORING AND ASSESSMENT:


Required Monitoring: • Weekly (First Month): Weight, blood pressure, heart rate, side effects • Bi-weekly (Months 2-3): Same parameters plus mood assessment • Monthly (Long-term): Comprehensive health evaluation • As Needed: ECG, lab work, psychiatric evaluation


Progress Tracking: • Daily weight measurements • Weekly body measurements • Food intake and appetite logs • Exercise tolerance and performance • Side effect severity ratings • Mood and energy assessments


Laboratory Monitoring: • Baseline: CBC, CMP, lipids, thyroid function, ECG • Monthly: Liver function, kidney function, electrolytes • Quarterly: Comprehensive metabolic assessment • Annual: Cardiovascular risk assessment


EXPECTED OUTCOMES:


Short-term (4-8 weeks): • Significant appetite reduction within days • Rapid initial weight loss (5-15 pounds) • Improved mood and energy (if well-tolerated) • Side effect adaptation


Medium-term (3-6 months): • 6-month weight loss results from research trials resulted in a weight loss of around 25 pounds • Sustained appetite control • Improved metabolic markers • Enhanced quality of life


Long-term (6+ months): • Maintained significant weight loss • Improved cardiovascular risk profile • Better metabolic health • Enhanced psychological well-being


CYCLING AND DISCONTINUATION:


Treatment Duration: • Clinical trials typically 24 weeks • Long-term use requires ongoing medical supervision • Periodic assessment for continued need • Gradual dose reduction when discontinuing


Discontinuation Protocol: • Gradual dose reduction over 1-2 weeks • Monitor for rebound appetite and weight gain • Implement intensive lifestyle modifications • Consider alternative maintenance strategies


Weight Maintenance: • Lifestyle modification critical for long-term success • Possible intermittent use protocols • Regular medical follow-up • Alternative appetite control strategies


CRITICAL SAFETY WARNINGS: 

Medical Supervision Required: Not for self-administration

Cardiovascular Monitoring: Essential due to stimulant effects

Psychiatric Screening: Required before initiation

Not for Mild Obesity: Reserved for significant weight loss needs

Regular Monitoring: Ongoing medical supervision essential


Important Notes: 

  • This compound requires strict medical supervision

  • Side effects can be serious and require immediate attention

  • Most side effects were mild to moderate and went away after some time, but long-term safety depends on having someone track your progress

  • Individual responses vary significantly

  • Lifestyle modifications essential for sustained success

 
 
 

Recent Posts

See All
EPITALON: TELOMERE EXTENSION AND LONGEVITY

OVERVIEW: Epitalon (also spelled Epithalon) is a synthetic tetrapeptide composed of four amino acids: Ala-Glu-Asp-Gly  Developed by Professor Vladimir Khavinson at the St. Petersburg Institute of Bior

 
 
 

Comments


bottom of page